I think that’s something Generex needs to make clear- where is the financing for the multiple acquisitions? What is the pending level of dilution? I’m not doubting them, but obviously they currently don’t have the available cash. There’s also another large acquisition Joe mentioned in the CC, and if accurate we should hear of that really soon. So, they need to show the money, and that should clarify things as far as GNBT becoming truly investable. Hopefully we read of an 8k showing that financial commitment very soon.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links